Balgrist News https://www.balgrist.ch/ en_EN balgrist.ch Mon, 24 Jun 2024 22:47:55 +0200 Mon, 24 Jun 2024 22:47:55 +0200 balgrist.ch news-710 Fri, 31 Jan 2025 08:58:00 +0100 Save the Date: Nerve and Muscle Ultrasound Teaching Course 2025 https://www.balgrist.ch//en/events/congresses-and-cpd/save-the-date-nerve-and-muscle-ultrasound-teaching-course-2025-710/ It is our great pleasure to announce our next Nerve and Muscle Ultrasound Teaching Course in January-February 2025. The next Nerve and Muscle Ultrasound Teaching Course will take place on January 31st and February 1st, 2025.

Save the date and stay tuned!

More information

If you wish to be notified when the registration opens, we are happy to add you to our mailing list. Please contact:

Balgrist University Hospital
Stephanie Chiesa
+41 44 386 38 32
Email

 

]]>
2024 Fachpersonen
news-686 Thu, 03 Oct 2024 10:34:00 +0200 Balgrist International Shoulder Course 2024 https://www.balgrist.ch/https://www.balgrist.ch/en/events/congresses-and-cpd/rotator-cuff-disorders/ Two-day course on Rotator Cuff Disorder. We are honored and proud to welcome an international faculty of world known shoulder surgeons, who will present their latest research, perform live surgeries and share their knowledge in interactive case discussions. Don‘s miss this opportunity and join us in one of the most beautiful cities in the world.

- Including Swiss Surgeons Sessions (featured by the Swiss Orthopaedic shoulder expert group)
- Reduced fee for Swiss Orthopaedic members

Faculty

Tjarco Alta, Amsterdam | Johannes Barth, Grenoble |Samy Bouaicha, Zurich | Patrick Denard, Medford | Florian Grubhofer, Zurich | Jay Keener, St. Louis | Laurent Lafosse, Annecy | Thibault Lafosse, Annecy | Philipp Moroder, Zurich | Patric Raiss, Munich | Markus Scheibel, Zurich | Olivier Verborgt, Bruxelles | Jon J.P. Warner, Boston | Jean-David Werthel, Paris | Members of the Swiss Orthopaedics shoulder expert group

Registration

Registration fee

Early bird fee until May 31st
CHF 400.-

Swiss Orthopaedics members
CHF 350.-

Registration

Venue

Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland

Download

Flyer (PDF)

Kontakt

Stefanie Pfister
Congress Coordinator
+41 44 386 38 33
Email

]]>
2024 Veranstaltungen Fachpersonen Klinik Events
news-743 Thu, 18 Jul 2024 13:30:00 +0200 Symposium on Modern Concepts in Implant Development https://www.balgrist.ch//en/events/congresses-and-cpd/symposium-on-modern-concepts-in-implant-development-743/ Symposium and workshop on the latest advancements in implant development The Ingenuity Lab at Balgrist University Hospital, Zurich, is inviting you to join an exciting symposium and workshop, where leading experts in translational implant development will address current challenges and share cutting-edge innovations. This convention offers a unique opportunity to connect with interdisciplinary researchers and explore the latest advancements in implants. We look forward to welcoming you to a collaborative symposium, providing a platform to discuss recent challenges and upcoming concepts in orthopedic research and implant development. Researchers and students from both translational and clinical sciences are welcome to join.

Program

Day 1 - July 18th, 2024

13.30 - 17.00 Symposium

  • Latest developments in surgical techniques for bone-tumor resection
  • Custom-made implants for defect reconstruction
  • 3D-printing technologies
  • Implant modification strategies

17.00 - 18.30 Networking Apéro

-> Registration by e-mail

Day 2 - July 19th, 2024

8.00 - 16.00 Hands-On Workshop

  • Invited experts will conduct pelvic reconstruction experiments in the Operating Room X (OR-X) using custom-made, 3D-printed implants. Limited spots available. For participation, please contact us in advance by e-mail.

Location
Balgrist University Hospital, Forchstrasse 340, 8008 Zurich

  • Day 1: Auditorium
  • Day 2: Operating Room X (OR-X)

Contact
Dr. Robert Nissler
robert.nissler@balgrist.ch
www.ingenuitylabz.com

 

]]>
2024 Fachpersonen
news-739 Wed, 19 Jun 2024 12:42:00 +0200 SEMS Course Zurich https://www.balgrist.ch//en/events/congresses-and-cpd/sems-course-zurich-739/ Law and sport, sports doctor and media, musculoscletal system, radiology upper extremity and spine, and exergaming. Content
  • Law and sport
  • Sports doctor and media
  • Musculosceletal system: shoulder and elbow
  • Musculosceletal system: hand
  • Musculosceletal system: spine
  • Biomechanics of the spine
  • Radiology upper extremity and spine
  • Exergaming

Time

19 - 21 June 2024, Wednesday to Friday 

Venue

Universitätsklinik Balgrist
Seminarraum OKB 61/62
Forchstrasse 319
8008 Zürich

Course Leader

Prof. Dr. med. Johannes Scherr
Prof. Dr. med. Samy Bouaicha

Course materials

Will be handed out at the beginning of the course. You can also find it on mydrive (see the program)

Program and details

Contact

Prof. Dr. med Johannes Scherr
Chefarzt und Leiter
Universitäres Zentrum für Prävention und Sportmedizin
Swiss Olymic Medical Center
johannes.scherr@balgrist.ch

Prof. Dr. med. Samy Bouaicha
Leitender Arzt Schulter- und Ellbogenchirurgie
Universitätsklinik Balgrist
samy.bouaicha@balgrist.ch

Stéphanie Ronner
Course Secretariat
Universitäres Zentrum für Prävention und Sportmedizin
Swiss Olymic Medial Center
T +41 44 386 52 15
stephanie.ronner@balgrist.ch

 

]]>
2024 Fachpersonen
news-741 Thu, 06 Jun 2024 09:40:47 +0200 Keyhole spinal surgery to combat rising healthcare costs https://www.balgrist.ch//en/about-us/media/keyhole-spinal-surgery-to-combat-rising-healthcare-costs-741/ Balgrist University Hospital (UKB), together with the EndoSpine Academy, is promoting the worldwide establishment of keyhole surgery for spinal treatments. The aim is to replace invasive operations and thus reduce healthcare costs. Nine top international surgeons are currently meeting in Zurich for the founding of the EndoSpine Academy. In recent years, Balgrist University Hospital has played a central role in the establishment of spinal surgery using the keyhole procedure (endoscopy); both in the corresponding patient care on site and internationally in research and development. The EndoSpine Academy was founded to make this gentle and predominantly outpatient method widely available. Nine internationally renowned endoscopy specialists travel to Zurich from China, the USA, Mexico, Jordan, Argentina, Germany and Korea. The aim of the EndoSpine Academy is to provide selected surgeons with access to high-quality training in the technique of minimally invasive spinal endoscopy. The first EndoSpine Academy course will be held at Balgrist University Hospital on June 6-7. 

Outpatient procedures are systematically promoted at Balgrist University Hospital, although the tariffs do not cover costs. Outpatient procedures meet the desire of patients to recover from an operation in familiar surroundings wherever possible. In addition, outpatient procedures help to reduce healthcare costs, a major concern of the two Balgrist directors, Prof. Mazda Farshad and Thomas Huggler. People treated on an outpatient basis make less use of the expensive infrastructure and do not generate costs for inpatient care and hotel services. 

Spinal endoscopy can replace some inpatient treatments

For Professor Farshad, Medical Director of the University Hospital Balgrist, the use of endoscopy is key to sustainably reducing the costs of spinal treatments: “Spinal endoscopy not only has a significantly lower risk of infection than open surgery, it can also replace treatment methods that require hospitalization. This means that certain fusion operations can be avoided".
Thomas Huggler, Operative Hospital Director, supports this medical development, even though it means a potential financial loss for the clinic. “As what is now the largest spinal center in Zurich, with several locations, over 24,000 consultations and 1,500 operations a year, we see it as our duty as a university institution to establish the surgery of tomorrow for patients today.”

 

Contact for further information
Gregor Lüthy, Head of Communication
Balgrist University Hospital
+41 44 386 14 15
E-mail

]]>
2024 Aktuelles
news-737 Wed, 29 May 2024 16:50:59 +0200 Jürg Stahl elected as new board member of the Swiss Balgrist Association https://www.balgrist.ch//en/about-us/media/juerg-stahl-elected-as-new-board-member-of-the-swiss-balgrist-association-737/ The Swiss Balgrist Association is pleased to announce that Jürg Stahl was elected to the Board of Directors by the Association's General Assembly on May 27. He succeeds Fritz Fahrni, who stepped down in 2023. Jürg Stahl brings impressive experience and wide-ranging expertise to his new role. He was a member of the National Council from 1999 to 2019 and served as its President for one year. Stahl was a member of the Social Security and Health Committee (SGK) for 20 years.   

In the past, Stahl was a member of the management of Groupe Mutuel, owner of his own drugstore and part-time marketing teacher. He has been President of Swiss Olympic since 2017 and will relinquish this position at the end of 2024 due to a term limit. He has been Central President of the Swiss Drugstore Association since 2018 and President of the Foundation Board of the Swiss National Science Foundation since 2020, a role for which he was proposed by the Federal Council. He is also an ambassador for the Talent Campus Bodensee.

With his extensive experience in the healthcare sector and his commitment, Jürg Stahl will be a valuable asset to the Board of the Swiss Balgrist Association. The President of the Association, Rita Fuhrer, warmly welcomes him and looks forward to working with him.

]]>
2024 Aktuelles
news-735 Tue, 28 May 2024 10:42:18 +0200 Balgrist University Hospital without loss in 2023 https://www.balgrist.ch//en/about-us/media/balgrist-university-hospital-without-loss-in-2023-735/ Balgrist University Hospital closed 2023 without a loss. This is not a matter of course in an environment that is increasingly creating headwinds for clinics and hospitals. Rising costs and outpatient services that still do not cover costs and are increasingly replacing inpatient treatment: This mix brings with it major challenges. Balgrist University Hospital achieved a net result of CHF 0.2 million in the 2023 financial year (2022: CHF 2.4 million) on revenue of CHF 221 million (+1.8 % compared to 2022). The clinic was once again able to increase both the number of inpatients (+ 3 %) and the volume of outpatient services (+ 5 %), which led to a solid result overall - despite the fact that the current outpatient tariff does not cover the costs. Despite the tense financial situation in the core business, all projects and activities in the areas of teaching and research were successfully driven forward at an excellent level of quality.

The doctors, therapists and nurses at Balgrist University Hospital treated 6715 patients in the inpatient SwissDRG area (orthopaedics / rheumatology / neurourology / neurology) in 2023. This corresponds to an increase of 3 %. The length of stay of 5.7 days was 0.3 days lower than in the previous year. The number of outpatient procedures rose by 10 % to 1113. Balgrist University Hospital is thus consistently implementing the shift of surgical procedures from the inpatient to the outpatient sector as demanded by politicians. At 1.36, the average case severity of DRG treatments remains above average. Personnel and material costs rose by 8 % and CHF 15.4 million respectively. In addition to growth-related higher personnel and material requirements, the cost trend was influenced in particular by inflation and the shortage of specialist staff. The number of treatment days at the Paraplegia Center is traditionally very volatile. It decreased slightly in the reporting year.

In the new 2024 financial year, the restrictions on logistical care and inflation are likely to cause operating expenses to rise. The new inpatient tariffs negotiated with the basic insurers will hardly fully compensate for the cost trend. The shift from inpatient treatment to outpatient care is likely to continue. Without a positive development in outpatient tariffs, the pressure on the operating result will continue. 

Annual Report 2023

 

Contact for further information
Gregor Lüthy, Head of Communication
Balgrist University Hospital
+41 44 386 14 15
E-mail

 

 

]]>
2024 Aktuelles
news-708 Thu, 14 Mar 2024 09:52:00 +0100 Balgrist University Hospital x Weltklasse Zürich: Starting signal for a new partnership https://www.balgrist.ch//en/about-us/media/balgrist-university-hospital-x-weltklasse-zuerich-starting-signal-for-new-partnership-708/ World class together. This is the motto of the new, multi-year partnership between Weltklasse Zürich and Balgrist University Hospital. When top-class sport meets top-class medicine, the shared high-performance spirit can be felt immediately. It can also be experienced and felt in the entrance area of Balgrist University Hospital, for example with the sprint track and athletics exhibition installed especially for the partnership kick-off. The two management teams officially launched the new partnership yesterday.

]]>
2024 Aktuelles
news-701 Wed, 17 Jan 2024 14:00:00 +0100 New study: improved visualization of bone healing https://www.balgrist.ch//en/about-us/media/new-study-improved-visualization-of-bone-healing-701/ The novel photon counting method in computed tomography enables better imaging of bone healing after orthopedic surgery. Image distortions from metal implants can now be significantly reduced by the use of a tin filter and monoenergetically reconstructed image data, a recent study has shown. The research was recently published in the renowned journal "Investigative Radiology". A pioneering study has shown that the visualization of bone healing in patients with metal implants can be significantly improved by the reduction of implant artifacts. The study was conducted by Dr. Adrian Marth, radiologist at the Swiss Center for Musculoskeletal Imaging at Balgrist Campus and led by Prof. Reto Sutter, Head of Radiology at Balgrist University Hospital. The researchers investigated the clinical benefit of the combination of tin prefiltration and virtual monoenergetic image reconstructions (VMIs) in CT examinations with a novel photon counting detector (PCD) CT system.
The study was conducted last year in 48 patients with metal implants in the feet or lower leg. VMIs with different energy levels between 60 kilo-electronvolts (keV) and 190 keV were created from the spectral image data to determine the optimal energy to reduce implant artifacts and improve the visibility of bone healing. The study demonstrated a significant advantage of CT imaging with tin prefiltration and VMIs at an energy level of 120 keV, which substantially improves the visualization of bone healing.
"To my knowledge, this is the first scientific study worldwide to show that the higher spatial resolution of photon counting CT has a clinical impact in the assessment of bone healing in patients. The significant reduction of metal implant artifacts due to tin prefiltration and monoenergetic image reconstruction and thus an overall higher image quality improves the visualization of bone healing. This is important for assessing the healing process in patients with metal implants," says Reto Sutter, Head of Radiology at Balgrist University Hospital.

Link to the study

Reference

Marth AA, Goller SS, Kajdi GW, Marcus RP, Sutter R. Photon-Counting Detector CT: Clinical Utility of Virtual Monoenergetic Imaging Combined With Tin Prefiltration to Reduce Metal Artifacts in the Postoperative Ankle. Investigative Radiology 2024 online before print

For further information please contact

Gregor Lüthy, Head of Communications
Balgrist University Hospital
+41 44 386 14 15
Email

]]>
2024 Aktuelles Balgrist News
news-691 Tue, 21 Nov 2023 08:31:59 +0100 Acne cream with a deep protective effect https://www.balgrist.ch//en/about-us/media/acne-cream-with-a-deep-protective-effect-691/ During shoulder joint surgery, acne bacteria can enter the surgical field and cause devastating infections of the shoulder joint. Applying a commercial acne cream to the shoulder area before the operation can prevent this. This was the finding of a study conducted in Balgrist University Hospital, which has been awarded three prestigious prizes. Together with many other types of bacteria, the skin bacterium Cutibacterium acnes acts as a protective film for a healthy skin climate, also in the shoulder area. Yet the acne bacterium has two sides: on the one hand, it protects the skin – apart from on the face of pubescent adolescents – on the other hand, it can trigger inflammations and complications in subcutaneous tissue.

When pain occurs due to infections following operations on the shoulder joint, acne bacteria play a part in over 60 % of cases. They are detected at the source of infection during the necessary follow-up operations. Thorough disinfection of the surgical site and antibiotic treatment are evidently unable to prevent their penetration.

However, if commercial acne cream is generously applied to the relevant shoulder every evening for a week before the operation, these acne bacteria no longer penetrate as far as the shoulder joint capsule. This was the finding of a recent study conducted among 60 patients at Balgrist University Hospital.

Two properties are critical for determining whether the acne bacteria can get as far as the joint capsule. Firstly, they primarily colonize sebaceous glands in the lower skin layer, especially around the hair root, and thus avoid surface skin disinfection. Secondly, they protect themselves with an antibiotic-resistant shell. “If the acne bacterium encapsulates itself to shield itself from antibiotics and thus reaches the shoulder joint capsule, it can infect the material inserted there, for example the prosthesis,” explained Dr. med. Ines Unterfrauner, first-time author of the studies. She added: “When cutting through the subcutaneous tissue during the operation, there is a risk that the bacterium gets inside the joint.”

The commercial acne cream selected for the study was proven to be effective because it contains two highly effective substances: the antibacterial substance benzoyl peroxide and the antifungal agent miconazole nitrate that, according to laboratory studies, also successfully eliminates antibiotic-resistant bacteria.

Sixty adult patients with an average age of 59 took part in the Balgrist study between November 2018 and May 2020. During the open shoulder operation, they first either received a prosthetic replacement joint or the joint was stabilized using the Latarjet procedure. Before the start of the study, the intended shoulder of all patients was examined for acne bacteria using a swab (sample 1). Half of the patients then applied Widmer Acne Creme Plus Widmer to the affected shoulder in the evening seven days before the procedure, while the other half did not. A further skin sample was taken from all patients in the operating theater before making the cut (sample 2). Samples of subcutaneous tissue (sample 3) and shoulder joint capsule (sample 4) were then taken during the operation. In 60 % of all patients, the shoulder was inhabited by acne bacteria prior to the start of the study (sample 1). Among these 60 %, the effectiveness of the acne cream could be seen before the procedure (sample 2). Here, the skin was free of acne bacteria in 10 of 18 patients. Among the subcutaneous samples, 17 of 18 patients were free of acne bacteria and, in particular, the joint capsule (sample 4) was free of acne bacteria in all patients treated with acne cream. In contrast, acne bacteria were found in the joint capsule in 4 of 19 untreated patients. In the subcutis (sample 3), 17 of 19 patients were free of acne bacteria, while only 6 out of 19 patients had no acne bacteria on the surface of the skin. If a comparison is performed between all participating patients, including those who had no acne bacteria on their skin in sample 1, the result is even clearer: acne bacteria was found in the joint capsule in 0 of 30 patients treated with the acne cream but in 5 patients who had not received the acne cream.

The Balgrist study also shows that acne bacteria in the joint capsule do not necessarily have to result in infections or inflammations. None of the patients, not even those with a positive acne bacteria result, had to be operated on again during the eleven-month follow-up period due to infections.

For first-time author Unterfrauner the most significant part of the study is the fact that, for the first time, the combined effect of the antibacterial substance benzoyl peroxide and the antifungal agent miconazole nitrate could be seen for the first time in operative procedures, as: “Studies with antibiotic treatment have not worked and antibiotics also have the disadvantage that they can develop resistance.”

Prof. Samy Bouaicha, who was responsible for running the study, referred to the practical benefit: “The pleasing results of our prospective study have led to our Shoulder Surgery team at Balgrist University Hospital routinely administering the acne cream for topical application on our patients a few days before planned surgical procedures.”

The study, which was published in the renowned Journal of Shoulder and Elbow Surgery in May 2022, has been awarded three prizes: the Neviaser Award for the best clinical paper from the Society of American Shoulder and Elbow Surgeons, the EFORT Free Paper Award Orthopedics for the best paper from the European Federation of National Associations of Orthopedics and Traumatology, and the Balgrist Research Award in Orthopedics for the best clinical paper from Balgrist University Hospital.

To the study

Contact for further information

Gregor Lüthy, Head of Corporate Communication
Balgrist University Hospital
+41 44 386 14 15
Email

]]>
2023 Aktuelles
news-688 Thu, 16 Nov 2023 10:00:00 +0100 Balgrist University Hospital opens Ingenuity Lab https://www.balgrist.ch//en/about-us/media/balgrist-university-hospital-opens-ingenuity-lab-688/ Balgrist University Hospital is opening the Ingenuity Lab for innovation in medical materials and technologies with a focus on orthopedic soft tissue research. Balgrist University Hospital and the University of Zurich have appointed Professor Inge Herrmann to their academic team. Inge Herrmann is a leading expert in the area of medical technology. She previously worked as a Professor at the ETH Zürich and at Empa where she will continue to perform tasks in research and teaching. Herrmann founded the Ingenuity Lab at Balgrist, which is specialized in innovative developments in the areas of medical materials and technologies with the aim of applying them in orthopedic soft tissue research.

The Ingenuity Lab will drive forward innovative research and development in the areas of materials, diagnostic equipment and therapeutic applications in the field of orthopedics. Among other things, the team is working on new tissue adhesive technologies for minimal-invasive and robot-supported surgery. Surgical adhesives with integrated sensors can be used to help detect infections and other complications in a timely manner. A further focus of the Ingenuity Lab is research into new treatment methods for radiation-resistant soft tissue tumors and anti-microbial resistance.

Under the leadership of Inge Herrmann, the research groups at the laboratory will work closely together with the clinical teams at Balgrist University Hospital to develop technology-based solutions that are customized to the biggest medical challenges. Inge Herrmann explained:

“Our vision at the Ingenuity Lab is to develop new solutions that are a direct response to the most urgent needs of the medical profession and patient care. We want to move the boundaries of medical technology. The combination of clinical excellence and innovative research is critical for developing the next generation of medical solutions. The Ingenuity Lab aims to exploit these synergies and offers a platform on which scientists, engineers and physicians can work together to design the medicine and medical technology of tomorrow.”

Balgrist University Hospital is known for its outstanding patient care and commitment to medical research and training. The opening of the Ingenuity Lab, just a few months after the OR-X, will further strengthen the hospital’s position as one of the leading centers for orthopedic research and treatment in Europe.

“We’re delighted to welcome Professor Herrmann and the Ingenuity Lab to Balgrist. This partnership underlines our commitment to innovation and excellence in orthopedics”, explained Professor Mazda Farshad, Medical Director of Balgrist University Hospital.

Contact for further information

Prof. Dr. Inge Herrmann
Balgrist University Hospital via Corporate Communication
+41 44 386 14 15
E-Mail

]]>
2023 Aktuelles
news-676 Fri, 25 Aug 2023 15:10:00 +0200 New OR-X research and teaching center officially opened https://www.balgrist.ch//en/about-us/media/new-or-x-research-and-teaching-center-officially-opened-676/ Balgrist University Hospital has opened OR-X (Operating Room X), its new surgical research and teaching center. In attendance at the opening were guests from the world of politics, healthcare, industry and medicine. Balgrist University Hospital has opened OR-X (Operating Room X), its new surgical research and teaching center. In attendance at the opening were guests from the world of politics, healthcare, industry and medicine. At the heart of the OR-X are the fully-equipped operating room and a Skills Lab, which offers an ideal environment for developing surgical innovations and training the surgeons of tomorrow. As the strategic infrastructure of University Medicine Zurich (UMZH), the OR-X supports academic research and plays a critical role in the further development of healthcare in the Zurich region.

On 24 and 25 August, Balgrist University Hospital celebrated the opening of its tenth operating room (Operating Room X, in short: OR-X). Over 250 invited guests took the opportunity to visit the room with its modern technical equipment and listen to the speeches from Rita Fuhrer, President of the Balgrist Association, Mazda Farshad and Thomas Huggler, the Hospital Directors, Martin Hirzel, President of Swissmem, and Philipp Fürnstahl, one of the OR-X co-founders.

Yet patients will never see the new OR-X. It is a national research infrastructure and the surgical teaching and research center at Balgrist University Hospital. It combines a realistic infrastructure with the latest technology and is accessible to national and international experts. The heart of OR-X is a fully-equipped operating room that was designed for the surgical research and training of tomorrow. It’s a place where new technologies are developed, experienced surgeons receive further training and future surgeons are trained.

The X not only stands for the number 10, but also the great potential that this digitalized research infrastructure offers. Teaching is performed without any direct contact to patients and using 3D-printed models, simulators and human preparations. The direct integration into a clinic and the connection to the existing research environment is unique. The technical highlights include intraoperative artificial intelligence (AI), navigation systems, operating robots and applications supported by augmented reality (AR).

With its six surgical workstations, the Skills Lab provides the perfect conditions for conducting training and larger research experiments with several participants.

Contact for further information:

Prof. Dr. med. Mazda Farshad, Medical Director, Balgrist University Hospital
via Corporate Communication
Tel +41 44 386 14 15
E-Mail

]]>
2023 Aktuelles
news-656 Tue, 18 Apr 2023 09:00:00 +0200 OR-X enters test operations https://www.balgrist.ch/https://or-x.ch/2023/04/18/or-x-enters-test-operations/ The OR-X translational research center has reached its next milestone: after only 15 months of construction, the infrastructure is ready for test operations. It has been handed over by the project management team to the users at Balgrist University Hospital. 2023 Aktuelles news-636 Fri, 31 Mar 2023 15:25:00 +0200 Nerve- and Muscle Ultrasound Teaching Course https://www.balgrist.ch//en/events/congresses-and-cpd/nerve-and-muscle-ultrasound-teaching-course-1-636/ It's our great pleasure to announce the 2023 Nerve- and Muscle ultrasound Teaching Course, which will take place March 31 and April 1st 2023 at Balgrist University Hospital in Zürich. We welcome all medical professionals interested in nerve ultrasound to participate at this course. You will find a valued exchange with ultrasound experts from different fields such as neurology, anesthesiology, radiology, rheumatology, neuro- and hand surgery. Emphasis is set on practical teaching lessons with hands-on workshops examining normal anatomy on models and pathological findings on invited patients.

In order to keep it as much instructive and interactive as possible, on-site places are restricted. As a novum, we outsourced the live streaming of the whole teaching course to the professional video and live streaming company yoveo, which makes the on-line participation also a very attractive option. There, we will again offer several interactive "ask the experts" sessions for the on-line participants during the on-site hands-on sessions.

Program

Course language
English

Venue
Balgrist University Hospital, Auditorium and seminar rooms
Forchstrasse 340, 8008 Zurich, Switzerland

Organizers
Dr. med Anne-Kathrin Peyer Kauffmann
Dr. med. David Lorenzana
Prof. Urs Eichenberger
Claudia Gasser-Fideeler, Chief Secretary
Department of Anaesthesia, Balgrist University Hospital

Faculty

  • Dr. med Anne-Kathrin Peyer Kauffmann, neurolgist, Privat Practice in Liestal and University Hospital Basel, Switzerland
  • Dr. med. David Lorenzana, anaesthesiologist, Head of Pain Medicine Department of Anaesthesia, Balgrist University Hospital, Switzerland
  • Prof. Urs Eichenberger, anaesthesiologist, Head of Department of Anaesthesia, Intensive Care and Pain Medicine, Balgrist University Hospital, Switzerland
  • Prof. Alexander Grimm, neurologist, University of Tübingen, Germany
  • Prof. Einar Wilder-Smith, neurologist, Kantonsspital Lucerne, Switzerland
  • Dr. med. Andras Schiller, neurologist, Privat Practice in Zürich, Switzerland
  • PD Dr. med. Maria Teresa Pedro, neurosurgeon, University of Ulm, Günzburg, Germany
  • Dr. med. Hannes Platzgummer, radiologist, University of Vienna, Austria
  • Dr. med. Zsuzsanna Arányi, neurologist, Semmelweis University of Budapest, Hungary
  • Dr. med. Christian Marx, rheumatologist, Privat Practice in Uster, Switzerland
  • PD Dr. med. Florian Hatz, neurologist, University Hospital Basel, Switzerland
  • Dr. med. Katrin Meyer, anaesthesiologist, Kantonsspital Lucerne, Switzerland
  • Dr. med. Stephan Mittas, neurologist, Kantonsspital Lucerne, Switzerland
  • PD Dr. med. Paolo Ripellino, neurologist, Ospedale Civico Lugano, Switzerland
  • KD Dr. med. Giorgio Tamborrini, rheumatologist, Privat Practice in Basel and University Hospital Basel, Switzerland
  • Prof. Dr. med. Esther Vögelin, handsurgeon, Inselspital Bern, Switzerland

Contact
Claudia Gasser
E-Mail

]]>
2023 Fachpersonen
news-366 Thu, 27 Oct 2022 07:45:00 +0200 Obligation to wear masks in case of cold symptoms https://www.balgrist.ch/ We ask all persons with cold symptoms to protect others from infection. Thank you for wearing a hygiene mask throughout the hospital. 2022 Aktuelles news-528 Thu, 06 Oct 2022 10:55:00 +0200 Collaboration with AO Foundation https://www.balgrist.ch//en/about-us/media/collaboration-with-ao-foundation-528/ Balgrist University Hospital and the AO Foundation are entering into a collaboration to create synergies in the areas of research, innovation, and education. The common goal is to optimize patient care and treatment outcomes in musculoskeletal diseases and trauma. The collaboration includes two jointly supervised PhD projects that begin in 2023.

With this collaboration, Balgrist University Hospital in Zurich and Davos-based AO Foundation are strengthening preclinical, translational, and clinical research in musculoskeletal medicine. Together with the AO Research Institute, Davos (ARI), the development of innovative and novel treatment methods and implants is being advanced for the benefit of patients. Furthermore, the research projects have the potential to achieve additional advances in surgical education and training.

A complementary win-win situation for patients

AO Executive Director Research and Development and ARI Director Geoff Richards says: "ARI is a research institute with a fully focused multidisciplinary research team on one campus and one of the top in the world when it comes to disc degeneration and regeneration, infection, and musculoskeletal biomechanics – the topics of the joint PhDs. Similarly, Balgrist University Hospital and their research units are very strong in translational sciences. This collaboration is a win-win due to proximity and complement of knowledge within our areas."

Professor Mazda Farshad, MD, Medical Director of Balgrist University Hospital, says: "We focus on translational research. As a leading orthopedic university hospital with an integrated paraplegia center, our physician scientists identify the problems that remain unanswered for patients and answer them together with basic researchers and developers. This fits perfectly with the founding philosophy of the AO. The historically grown research and innovation focuses of Balgrist University Hospital and the AO complement each other, and, when combined, will make Switzerland the country with the highest impact on musculoskeletal medicine."

Two joint PhD projects in 2023

The collaboration has already begun and includes two jointly supervised PhD projects that start in 2023 focusing on research projects at ARI and Balgrist University Hospital. One of the projects is on functionalized annulus fibrosus repair patch to prevent post-surgical disc complication and the other is on patient-specific optimization of spinal fusions using validated computer simulations.

News AO-Foundation

AO Research Institute

For additional information please contact

via Franziska Ingold, Head of Corporate Communications, Balgrist University Hospital
+41 44 386 14 15
kommunikation@remove-this.balgrist.ch

via Olga Harrington, Head of Corporate Communications, AO Foundation
+41 79 834 57 42
communications@remove-this.aofoundation.org

]]>
2022 Aktuelles
news-501 Thu, 28 Jul 2022 11:40:15 +0200 Center of excellence for spine surgery https://www.balgrist.ch//en/about-us/media/center-of-excellence-for-spine-surgery-501/ Founded in 2017, the University Spine Center Zurich has been certified a "Surgical Spine Center of Excellence" by the spine society EuroSpine. The Spine Center is a cooperation of eight different disciplines and the interdisciplinary team consists of specialists who dedicate themselves daily to the treatment of patients with spine problems. We thank our patients for their trust, which is reflected in about 20,000 consultations and more than 1300 operations per year. The certificate as Center of Excellence for Spine Surgery expresses the high quality standards of the University Spine Center Zurich and confirms us on our way to provide the best possible treatment for patients.

Find out more:
www.balgrist.ch/spine

]]>
2022 Aktuelles
news-467 Tue, 17 May 2022 13:27:00 +0200 Federation to support 12 million franc project https://www.balgrist.ch//en/about-us/media/federation-to-support-12-million-franc-project-467/ The Swiss Innovation Agency (Innosuisse) is supporting the PROFICIENCY project with 6 million Swiss francs. The project constitutes a paradigm shift in education and training for surgeons. Innovative, simulator-supported practical training will replace advanced training in the operating room. State-of-the-art technological developments make it already possible to simulate many sur-gical procedures in a true-to-life manner. However, a large part of the surgical  education  still happens in the operating room and during patient treatment. The PROFICIENCY pro-ject will enable a critical paradigm shift: Future surgeons will be able to learn and improve their surgical skills through highly-realistic simulator-supported training – without compro-mising patient safety. PROFICIENCY is build upon two columns. On the one hand, a modular curriculum will be developed that will be accessible on a digital learning platform. On the other hand – and this is very important– cutting-edge digital technologies will be de-veloped to make surgicaltraining more realistic, immersive and effective. The Swiss Inno-vation Agency (Innosuisse) supports the project, which has a total volume of 12 million Swiss francs, with a total of 6 million Swiss francs over the next four years.

Prof. Dr. sc. Philipp Fürnstahl, principal investigator at Balgrist University Hospital, ex-plained the significance of «PROFICIENCY» for surgical training: «The use of artificial in-telligence and augmented reality heralds the dawn of a new era for highly specialized surgi-cal training. In just a few years, the first prototypes can be integrated into highly modern learning centers such as the OR-X at Balgrist University and made available to young sur-geons.»

Researchers and developers from Balgrist University Hospital and the Balgrist Campus have researched, developed and tested the surgical innovations behind «PROFICIENCY». These innovations stem from the SURGENT (Surgeon Enhancing Technologies) project and also forms the basis for the new, translational OR-X teaching and research center. The OR-X center is currently under construction and will be brought into operation at Balgrist University Hospital next year.

«PROFICIENCY» is a cooperation between Balgrist University Hospital, Zurich University, ETH Zurich, Cantonal Hospital of St. Gallen, the Centre hospitalier universitaire vaudois (CHUV), Zurich University of Applied Sciences (ZHAW) and the four companies VirtaMed AG, Microsoft Schweiz GmbH, ORamaVR S.A. and Atracsys LLC.


More Information
PROFICIENCY
Innosuisse

Contact for additional Information
Prof. Dr. sc. Philipp Fürnstahl, via Franziska Ingold, Head of Corporate Communications, Balgrist University Hospital
+41 44 386 14 15, kommunikation@remove-this.balgrist.ch

 

]]>
2022 Aktuelles
news-463 Mon, 09 May 2022 13:27:00 +0200 FAROS Integration Week https://www.balgrist.ch//en/about-us/media/faros-integration-week-463/ From May 9 to 13, the FAROS Integration Week took place at Balgrist. As the research and development work of this HORIZON-2020 project is done in parallel in different European partner facilities, integration weeks take place regularly. They serve to synchronize and test the sensors, functional models and controls. The international research collaboration aims to develop surgical robots that use a wide range of sensory perceptions to autonomously perform complex surgical tasks.
 

«FAROS» a consortium of four universities: KU Leuven in Belgium, which is coordinating the project and driving the work in non-visual sensing, Sorbonne University in France, with a strong role in robotics, King's College London in England, which will lead the development of artificial intelligence, and Balgrist University Hospital / University of Zurich, which will work clinically, experimentally and interdisciplinary to ridge robotics, computer science and clinical research. The project has received funding from the European Union’s Horizon 2020 research and innovation programme. «FAROS» started with a three-year term on January 1, 2021.

 

More Information

FAROS-Balgrist
FAROS-Website
 

]]>
2022 Aktuelles
news-389 Wed, 26 Jan 2022 16:51:00 +0100 Operating Room X: start of construction https://www.balgrist.ch//en/about-us/media/operating-room-x-green-light-for-the-start-of-construction-389/ Construction work starts today on the OR-X, the new Translational Center for Surgery at Balgrist University Hospital. The test phase for the OR-X will be launched in the first quarter of 2023. The OR-X (Operating Room X) at Balgrist University Hospital is a new, translational surgical research and teaching Center. The first construction phase will start on Wednesday 26 January 2022, which constitutes a milestone for this significant project at Balgrist University Hospital. The launch of the test phase is scheduled for the first quarter of 2023. The OR-X will create new opportunities for surgical research, development and teaching, based in Zurich but with national relevance. Researchers and developers will be able to develop and validate new technologies and innovations more efficiently. New technologies can therefore be used in clinical applications more quickly (translation). Future surgeons can learn and gather surgical experience in a realistic operating theater – without endangering patient safety.

Visit OR-X website


For further information, contact 
Prof. Dr. med. Mazda Farshad
Medical Director, Balgrist University Hospital

via Franziska Ingold
Head of Communications, Balgrist University Hospital
+41 44 386 14 15
Email

]]>
2022 Aktuelles
news-368 Fri, 01 Oct 2021 13:33:00 +0200 Surgery «Dropped Head Syndrom» https://www.balgrist.ch//en/about-us/media/surgery-dropped-head-syndrom-368/ Thanks to a cutting-edge new surgical technique, a patient with Dropped head syndrome was successfully treated without the necessity of me-tallic implants and fusion. The surgical technique was developed at the University Spine Center Zurich. Dropped head syndrome (DHS), also known as floppy head syndrome, is a rare condition with a broad differential diagnosis. DHS has a considerable impact on the health and qual-ity of life of affected individuals. The neck extensors are weakened to such an extent that patients are unable to hold the head erect. Until now, extensive fixation and fusion of the cervical and thoracic spine has been the only possible treatment for DHS.

Prof. Mazda Farshad, Surgeon in Chief and Director of the University Spine Center Zurich at Balgrist University Hospital, and his team have now developed a new surgical technique making it possible to treat DHS for the first time successfully without fusion. This tech-nique, known as «occipitopexy», supports the head by using ligaments attached to the spine. Today, eighteen months after surgery, the patient, a 68-year-old female, is not only still able to support and maintain a normal head position, but also perform head movement functionality. This represents a less radical and very promising treatment to relieve the pa-tients’ suffering without restricting their quality of life by spinal fusion.

For further information, contact
Prof. Dr. med. Mazda Farshad, Medical Director, Balgrist University Hospital

Via Franziska Ingold, Head of Communications, Balgrist University Hospital
+41 44 386 14 15 / E-Mail

]]>
2021 Aktuelles
news-331 Thu, 21 Jan 2021 09:59:41 +0100 FAROS is the new EU Horizon project https://www.balgrist.ch/https://www.balgrist.ch/en/research/research-units/research-orthopaedics/faros/ The FAROS project aims to develop the next generation of surgical robotics that that scan, hear, feel and act. The research project brings together leading European institutes. Aktuelles news-328 Fri, 11 Dec 2020 09:21:41 +0100 First holographically navigated spine surgery https://www.balgrist.ch//en/research/research-units/augmented-reality/ A team at Balgrist University Hospital successfully completed the first holographically navigated spine surgery. Aktuelles news-300 Wed, 26 Aug 2020 17:36:37 +0200 Balgrist researcher awarded the Schellenberg Research Prize 2020 https://www.balgrist.ch/https://www.irp.ch/irp-schellenberg-research-prize/ The IRP Schellenberg Research Prize 2020 is awarded to Professors Patrick Freund, Balgrist University Hospital, Switzerland, and Jonas Frisén, Karolinska Institute, Sweden. The award ceremony will take place on October 1st, 2020 in Basel. Aktuelles news-290 Thu, 25 Jun 2020 12:58:00 +0200 Augmented reality world premiere https://www.balgrist.ch//en/about-us/media/augmented-reality-world-premiere-290/ An interdisciplinary team is laying the foundations for a pioneering study with holographically navigated spine surgery. At Balgrist University Hospital, for some years a team of experts from the fields of research, engineering and surgery have been looking at the possibility of augmented reality (AR) to assist with operations on the spine. Imaging data on AR glasses should soon make orthopedic operations more efficient, precise, and safer for the patient. Balgrist University Hospital is laying the foundations for this with the first clinical study of its type in the world.

“A prominent milestone on the way towards orthopedics shaped by computer technology, with the goal of allowing fully digitalized treatment”, says Prof. Philipp Fürnstahl, Head of ROCS at Balgrist.

The study, which was approved by Swissmedic, is being carried out as part of Zurich University Medicine’s SURGENT (Surgeon Enhancing Technologies) Flagship Project. Together with their technology partner, Microsoft, Balgrist ROCS (Research in Orthopedic Computer Science) and Incremed, a university start-up supported by Balgrist Beteiligungs AG, are currently testing AR-based surgical navigation in orthopedics. “In orthopedics, augmented reality is the key to creating new standards for carrying out precise patient-specific surgery. Thanks to the cooperation between the Zurich University, the University hospitals and the ETH, Zurich is at the cutting edge globally,” says Prof. Dr. med. Mazda Farshad, Head of the Flagship Project and Chief Medical Officer of Balgrist University Hospital.


An important step for AR technology in the operating roomIn the first study of its type to be carried out anywhere in the world, complex surgical operations on the spine will be performed with or without holographic navigation, following a randomization procedure. The results of the initial phase are expected to be available in autumn 2020. A comparison of the groups should provide the basis for an important step towards bringing AR technology from the research laboratory into operating theatres across the world. Prof. Philipp Fürnstahl, Head of ROCS at Balgrist, sees it as “a prominent milestone on the way towards orthopedics shaped by computer technology, with the goal of allowing fully digitalized treatment.” And Marianne Janik, CEO of Microsoft Switzerland, adds “Cooperation with Balgrist University Hospital shows that augmented reality and artificial intelligence can already support and even enhance human abilities and expertise. We are proud that our technology meets the very high quality requirements and that we can contribute to this pioneering work.”
 

Benefits for patients
3D images of the affected anatomy are generated on the basis of CT scans and displayed directly in the surgical field during the operation. Surgeons can see the patient’s 3D anatomy using AR glasses. The AR navigation software guides each step of the operation. For example, it shows the exact placement of a screw at the correct site and the appropriate angle, and verifies the accuracy. In addition to the precise positioning of implant components, rod implants can be measured and thus individually dimensioned. This allows an enhancement of the surgeon’s perceptive senses.


For further information, contact
Franziska Ingold, Heas of Communications
Balgrist University Hospital
+41 44 386 14 15
Email

]]>
Aktuelles
news-286 Thu, 18 Jun 2020 09:32:24 +0200 MRI study shows bone changes in the knee https://www.balgrist.ch//en/about-us/media/mri-study-shows-bone-changes-in-the-knee-286/ A study with junior ski athletes has found that more than half of the junior skiers have "distal femoral cortical irregularity" (DFCI). The study is a joint research project of the Radiology and Sports Medicine departments of Balgrist University Hospital in Zurich, Switzerland. The researchers examined the knee joints of youth competitive alpine skiers for the presence of distal femoral cortical irregularities (DFCIs). These are typically found at the attachment site of tendons on the posterior aspect of the femoral bone. These changes were present in more than half of the athletes while significantly fewer subjects in the control group were affected. It is thus clear that these DFCIs are of mechanical origin.

«The successful research project is an example of the interdisciplinary research activities at Balgrist University Hospital.»

A DFCI is usually an incidental finding on an MRI scan of the knee and often does not cause any symptoms. However, in the past such findings were often misinterpreted as tumors. The results of the study, which was published in the renowned journal Radiology, will considerably facilitate the diagnostic evaluation of such “pseudo-lesions”. In future, follow-up investigations and invasive bone biopsies will no longer be necessary. The successful research project is an example of the interdisciplinary research activities at Balgrist University Hospital, where researchers identify clinical problems in patients and translate them into corresponding scientific questions.

Distal femoral cortical irregularity (DFCI) on Knee MRI: Increased prevalence in youth
competitive alpine skiers. Stern C, Galley J, Fröhlich S, Peterhans L, Spörri J, Sutter R.
Radiology, 2020. [Epub before print] doi:10.1148/radiol.2020192589

Link to the study
 

For further information, contact
PD Dr. med. Reto Sutter, Chief of Radiology
via Franziska Ingold, Heas of Communications
Balgrist University Hospital
+41 44 386 14 15
Email

]]>
Aktuelles
news-277 Fri, 17 Apr 2020 07:46:47 +0200 Neuer Stv. Medizinischer Spitaldirektor https://www.balgrist.ch//en/about-us/media/armin-curt-zum-stv-medizinischer-spitaldirektor-ernannt-277/ Die Universitätsklinik Balgrist hat Prof. Dr. med. Armin Curt, Chefarzt und Direktor Zentrum für Paraplegie, zum Stv. Medizinischen Spitaldirektor befördert. Prof. Dr. med. Armin Curt, Chefarzt und Direktor des Zentrums für Paraplegie, wird per 1. Mai 2020 zum Stv. Medizinischen Spitaldirektor befördert.

Seit elf Jahren ist Prof. Armin Curt Ordinarius für Paraplegiologie an der Universität Zürich und Chefarzt und Direktor des Zentrums für Paraplegie an der Universitätsklinik Balgrist. Er führt ausserdem die Forschergruppe für Paraplegie im Balgrist Campus. Das Team betreibt intensive Grundlagenforschung der Querschnittlähmung und des Rückenmarks. Curt misst der klinischen Forschung grosse Bedeutung zu und war massgeblich an den Forschungserfolgen seines Fachgebiets beteiligt. Gegenwärtig leitet er die europäische NISCI-Studie.

Nach dem Medizinstudium an der Universität Köln und der Ausbildung in Neurologie und klinischer Neurophysiologie begann er an der Universität Zürich seine Spezialisierung in der Versorgung und Rehabilitation von Rückenmarkverletzungen. Von 2005 bis 2008 war er ausserordentlicher Professor für Neurologie und SCI-Forschung an der University of British Columbia Vancouver, Kanada. Er ist Träger von zahlreichen nationalen und internationalen Stipendien, Ehrungen und Preisen. Seine primären Interessen sind translationale Forschung im menschlichen SCI, Neuro-Rehabilitation, klinische Neurophysiologie und Neuro-Imaging im menschlichen SCI.

Prof. Dr. med. Mazda Farshad: «Ich freue mich sehr, dass mit Prof. Dr. med. Armin Curt die Stellvertretung meiner Funktion als Medizinischer Direktor der Universitätsklinik Balgrist optimal sichergestellt ist. Die Zusammenarbeit mit ihm ist seit mehreren Jahren etabliert und im Rahmen des Universitären Wirbelsäulenzentrums Zürich noch weiter intensiviert worden.»

]]>
Aktuelles
news-276 Tue, 14 Apr 2020 18:09:41 +0200 Neue Stellvertreter der Orthopädie-Direktion https://www.balgrist.ch//en/about-us/media/neue-stellvertreter-der-orthopaedie-direktion-276/ Die Universitätsklinik Balgrist hat zwei neue Stv. Direktoren Orthopädie: PD Dr. med. Patrick Zingg (Klinik) und Prof. Jess Snedeker (Forschung). PD Dr. med. Patrick Zingg und Prof. Jess Snedeker werden zu Stv. Direktoren Orthopädie befördert; Patrick Zingg für den klinischen Bereich, Jess Snedeker für den Bereich Forschung Orthopädie. Sie treten die Nachfolge des Anfang Jahr verstorbenen Prof. Dr. med. Dominik Meyer an.

PD Dr. med. Patrick Zingg ist seit 2017 Leiter Hüft- und Beckenchirurgie und seit bald 20 Jahren an der Universitätsklinik Balgrist. Seine Spezialisierungen sind die gelenkserhaltende Chirurgie bei Impingement und bei Dysplasie (Hüftarthroskopie, periacetabuläre Beckenosteotomie, femorale Umstellungsosteotomie), die Prothetik (künstlicher Gelenksersatz) und die Revisionsprothetik (Prothesen-Wechsel, Rekonstruktion von Knochendefekten und Muskelschäden).

Prof. Jess Snedeker ist der Chief Scientific Officer des Balgirst Campus und seit bald 15 Jahren Leiter der Orthopädischen Biomechanik-Forschung an der Universitätsklinik Balgrist. Das Labor für Orthopädische Biomechanik ist eine multidisziplinäre Forschungseinheit, die sich wissenschaftlichen Fragen rund um den Bewegungsapparat widmet. Prof. Snedeker ist Inhaber eines gemeinsamen Lehrstuhls an der Universität Zürich und der ETH Zürich.

Prof. Dr. med. Mazda Farshad: «Es freut mich, dass mit der Beförderung von PD Dr. Patrick Zingg und Prof. Jess Snedeker die Stellvertretung meiner Funktion als Direktor Orthopädie hervorragend aufgestellt ist.»

]]>
Aktuelles
news-271 Tue, 07 Apr 2020 08:27:01 +0200 Neuer Chefarzt Handchirurgie https://www.balgrist.ch//en/about-us/media/neuer-chefarzt-handchirurgie-271/ Andreas Schweizer tritt die Nachfolge von Ladislav Nagy an und wird neuer Chefarzt der Handchirurgie. Prof. Dr. med. Ladislav Nagy ist es seit 2002 gelungen, an der Universitätsklinik Balgrist eine international renommierte Handchirurgie aufzubauen und laufend weiterzuentwickeln. Ausserdem hat er es verstanden, einen exzellenten Nachfolger aufzubauen. Im Hinblick auf seine bevorstehende Pensionierung ist es Professor Nagys Wunsch, die Führungsaufgaben jetzt abzugeben. Er selbst wird der Universitätsklinik Balgrist sowie den Patientinnen und Patienten als Senior Consultant weiterhin zur Verfügung stehen.

2007 stiess Prof. Dr. med. Andreas Schweizer zur Universitätsklinik Balgrist. Mit innovativen Ideen hat er beträchtlich dazu beigetragen, die Handchirurgie an der Universitätsklinik Balgrist klinisch und akademisch voranzutreiben. Er gilt in seinem Fach als internatio-naler Experte und wird mit seinem Team das gesamte Spektrum der orthopädischen Handchirurgie sowie der peripheren Nervenchirurgie abdecken können.

Prof. Dr. med. Mazda Farshad, medizinischer Spitaldirektor der Universitätsklinik Balgrist, zum Wechsel in der Handchirurgie: «Ich freue mich, dass wir die Nachfolge der Leitung unserer Handchirurgie derart gezielt angehen konnten. Durch die interne Lösung ist die kontinuierliche Weiterentwicklung gewährleistet.»

Kontakte für weitere Informationen
Via Franziska Ingold, Leiterin Kommunikation
Universitätsklinik Balgrist
+41 44 386 14 15
E-Mail

]]>
Aktuelles
news-270 Fri, 03 Apr 2020 10:21:00 +0200 Gesichtsschutz aus dem 3D-Drucker https://www.balgrist.ch//en/about-us/media/schutzmasken-aus-dem-3d-drucker-270/ Masken und Brillen zum Schutz vor dem neuen Coronavirus sind weltweit Mangelware. Das Forscherteam ROCS entwickelt zusammen mit dem Balgrist Campus und Balgrist Tec eine Art «face shield» für das Spitalpersonal. Das Team Research in Orthopedic Computer Science (ROCS) hat sich in der aktuellen, durch das neue Coronavirus verursachten Pandemielage mit den 3D-Druck-Spezialisten der Universitätsklinik Balgrist, der Balgrist Campus AG und der Balgrist Tec AG zusammengetan. Das Team hat eine innovative Lösung zur Bekämpfung des drohenden
Mangels an Schutzmaterial für das ganze Gesicht entwickelt.

Mit den eigenen 3D-Druckern werden ab sofort eigene Gesichtsschutze hergestellt. Die 3D-gedruckten Masken sind sterilisierbar und mit einer austauschbaren, sich nicht beschlagenden Spezialfolie versehen. Die ersten dieser Masken werden bereits in der Universitätsklinik Balgrist getestet und verwendet. Mit dieser Eigeninitiative leisten wir am Balgrist einen kleinen Beitrag zum Schutz des Spitalpersonals, das im Moment aussergewöhnliche Leistungen erbringt.

Hochpräzise Operationen dank Computertechnologie
Das ROCS ist ein interdisziplinäres und ambitioniertes Team aus Forschern, Ingenieuren und Chirurgen. Sie haben sich zum Ziel gesetzt, die Behandlung von Erkrankungen des Bewegungsapparates durch den Einsatz von Computertechnologie stetig zu verbessern. Zur ROCS-Forschungsgruppe gehört auch das Zentrum 3D-Planung und 3D-Druck der Universitätsklinik Balgrist, das die Chirurgen für schwierige orthopädische Operationen beiziehen können. Mit Hilfe von Computersimulation, Augmented Reality und 3D-Druck erarbeiten sie eine individuell auf den Patienten zugeschnittene Lösung und die Operation kann hochpräzise durchgeführt werden.
 

Kontakte für weitere Informationen
Prof. Dr. med. Mazda Farshad, Universitätsklinik Balgrist
Prof. Dr. Philipp Fürnstahl, Universitätsklinik Balgrist

Via Franziska Ingold, Leiterin Kommunikation
Universitätsklinik Balgrist
+41 44 386 14 15
E-Mail

]]>
Aktuelles
news-268 Thu, 26 Mar 2020 15:18:00 +0100 Universitätsklinik Balgrist eröffnet Intensivstation https://www.balgrist.ch//en/about-us/media/universitaetsklinik-balgrist-eroeffnet-intensivstation-268/ Die Universitätsklinik Balgrist kann ihre Intensivstation und den Aufwachraum früher als geplant eröffnen und schafft so zusätzliche IPS-Kapazitäten. Die Inbetriebnahme der neuen Infrastruktur erforderte in den Tagen vor der Eröffnung eine erhöhte personelle Besetzung. Nur dank des engagierten Einsatzes und der Flexibilität des Spitalpersonals konnte diese früher als geplant eröffnet werden. Die Sicherheit der Patientinnen und Patienten hat oberste Priorität – alle Geräte zur Überwachung auf der Intensivstation wollen getestet sein und einwandfrei funktionieren. 

Behandlung von komplexen orthopädischen und paraplegischen Fällen
Der Balgrist hat als Universitätsklinik einen universitären Versorgungsauftrag und führt nebst der hochspezialisierten Diagnostik auch die Behandlung von komplexen Fällen in den Fachbereichen Orthopädie und Paraplegie durch. Mit der neuen Intensivstation und des Aufwachraums stellen wir sicher, dass die Versorgung von komplexen Behandlungen und seltenen Erkrankungen weiterhin gewährleistet ist.

  • Prof. Mazda Farshad, medizinischer Spitaldirektor: «Die Intensivstation ermöglicht die Behandlung aller orthopädischen Patienten, auch wenn es mal sehr kompliziert wird. Das differenziert die Universitätsklinik Balgrist als orthopädische Spezialklinik und erlaubt ihr die Tertiärversorgung.»

Auf der Intensivstation werden komplexe orthopädische Patientinnen und Patienten postoperativ intensivmedizinisch überwacht und gepflegt. Bei querschnittgelähmten Patienten stehen die Stabilisierung der lebenswichtigen Funktionen, die Prävention und Behandlung von Komplikationen, die Beatmung sowie die Schmerz- und Atemtherapie im Vordergrund.

Aktuell würden positiv auf das Coronavirus getestete Patienten isoliert und somit getrennt von orthopädischen oder paraplegischen Patienten behandelt. Damit kann die Universitätsklinik Balgrist das Gesundheitssystem tatkräftig unterstützen und mithelfen, den Ansturm auf die Akutspitäler zu entlasten.

Kontakt und Informationen
Kommunikation
+41 44 386 14 15
E-Mail

]]>
Aktuelles
news-266 Mon, 16 Mar 2020 14:54:35 +0100 Virtual consultation as a supplementary service https://www.balgrist.ch//en/about-us/media/virtual-consultation-266/ In view of the current position regarding the coronavirus, Balgrist University Hospital is offering virtual consultations as a supplementary service for outpatients. As a University Hospital, we accept our responsibility for implementing the instructions of Switzerland’s Federal Office of Public Health (FOPH) and the Health Department of the Canton of Zurich, and protecting our patients to the best of our abilities.
 

Telephone and video consultations
From now on, outpatients can communicate directly with their doctor by phone or by video, as a supplement to their regular appointments. Of course, we offer this option as a priority to particularly vulnerable patient groups. This emergency measure allows us to make an important contribution to the safety of our patients.

Please do not hesitate to contact the relevant secretary’s office if you have any questions or need any assistance.

]]>
Aktuelles
news-255 Sat, 01 Feb 2020 14:38:00 +0100 Professur für Orthopedic Computer Science https://www.balgrist.ch//en/about-us/media/neue-professur-fuer-orthopedic-computer-science-255/ Die Universität Zürich hat Prof. Dr. Philipp Fürnstahl per 1. Februar 2020 zum Professor für «Orthopädische Forschung mit Schwerpunkt Computer Science» ernannt. Prof. Dr. Philipp Fürnstahl ist einer Berufung durch die Universität Zürich gefolgt. Er übernimmt per 1. Februar 2020 einen Forschungs- und Lehrauftrag in orthopädischer Forschung mit Schwerpunkt Computer Science. Philipp Fürnstahl wird für die medizinische und naturwissenschaftliche Fakultät tätig sein und ist der Universitätsklinik Balgrist institutionell zugeordnet. Seine Forschung wird ein breites Spektrum von Gebieten der Informatik mit der Orthopädie vereinen, wie maschinelles Lernen, künstliche Intelligenz, Simulation und Augmentierte Realität, und die Translation in die Klinik sicherstellen. 


Prof. Philipp Fürnstahl

Prof. Dr. med. Mazda Farshad: «Die Professur «Computer Science in orthopedics» will in enger Zusammenarbeit mit den Ärzten die Behandlung der Patienten verbessern. Dafür werden neuste Computertechnologien erforscht, entwickelt und eingesetzt. Wir freuen uns auf die Ausweitung dieser bereits erfolgreichen Forschungsgruppe.»
 

ROCS - Research in Orthopedic Computer Science
An der Universitätsklinik Balgrist betreibt ein interdisziplinäres und ambitioniertes Team aus Forschenden, Ingenieurinnen, Ingenieuren, Chirurginnen und Chirurgen Forschung in computerassistierter, orthopädischer Chirurgie. Das Ziel ist, die Behandlungsmethoden von Krankheiten am Bewegungsapparat durch den Einsatz von Computertechnologie stetig zu verbessern.

Durch die Schaffung der neuen Professur wird das Forschungsteam um Philipp Fürnstahl breiter aufgestellt und neu strukturiert. ROCS – Research Orthopedic Computer Science. Der interdisziplinäre Charakter zeichnet dieses Forschungsteam aus mit Grundlagenforschern der Computer Science und Mediziner.  Neben der Forschung wird ein Teil des Teams in Form des «Zentrums für 3D-Operationsplanung und 3D-Druck» für die Patientenbehandlung tätig sein und die Chirurgie mit Computermethoden bei komplexen orthopädischen Operationen unterstützen.

]]>
Aktuelles
news-219 Thu, 12 Sep 2019 10:00:00 +0200 Promising treatment for people with tetraplegia https://www.balgrist.ch//en/about-us/media/promising-treatment-for-people-with-tetraplegia-219/ A new therapy with antibodies gives reason for hope for patients with acute spinal cord injury. Recovery from acute spinal cord injury is unfortunately very limited and at present there are no medications available to treat the damaged spinal cord. Until now, rehabilitation has always been the most effective way of treating patients with spinal cord injuries. New medications with antibodies could be the breakthrough and allow the first real therapy for damaged nerves in the spinal cord.

 

For the first time, it seems possible to improve the recovery of nerve function using a medication that also helps patients recover considerably better. The new antibodies, an endogenous inhibitor,(Nogo-A protein), which prevents growth and regeneration of nerve fibres, can be blocked in humans. The treatment aims to improve the regeneration and plasticity of the nerve fibres so that they can reunite. This should considerably improve both the motor and sensory functions and the patient’s quality of life.

This antibody therapy is currently being tested in a clinical trial that is being conducted across Europe, which is looking at patients in the first few weeks of an accident causing tetraplegia. Prof. Armin Curt, Director of the Spinal Cord injury Centre at Balgrist University Hospital, is coordinating the project.

For further information please contact

Balgrist University
Communications

+41 44 386 14 15

]]>
Aktuelles
news-213 Thu, 22 Aug 2019 13:48:34 +0200 Safer operations thanks to 3D operation planning https://www.balgrist.ch//en/about-us/media/safer-operations-thanks-to-3d-planning-and-surgical-navigation-213/ Balgrist University Hospital and Balgrist Campus complete their HSM2 project very successfully. In the project, clinical and campus have significantly advanced and further developed computer-assisted patient-specific 3D surgical planning. The methods enable novel surgical treatment options, provide greater patient safety, and improve outcome quality.

Focus on expansion of 3D planning methods

The new shoulder model developed by the researchers as part of the project, can be considered as one of the most comprehensive computer models for simulating patient-specific motions or bone and soft tissues pathologies. It includes three joints and 23 muscle components, including muscle fibres. In addition, the researchers were able to develop new methods for 3D planning and surgical navigation of tumour surgeries.

Great advances were also made in the surgical navigation of bone pathologies. Computer models combined with 3D printing allow highly accurate surgical planning tailored to the patient. The navigation system used is based on 3D-printed instruments that enable the surgeon to perform cutting and drilling highly accurate within millimeter accuracy. Clinical studies have shown that patients can be operated on more precisely, faster, and safer using these methods.

For further information please contact

Balgrist University Hospital 
Communications
+41 44 386 14 15

]]>
Aktuelles